Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
Savan K. Patel(Broad Institute), Michael J. Mitchell(California Institute for Regenerative Medicine), Karin Wang(Temple University), Jingya Qin(University of Pennsylvania), Kelsey L. Swingle(University of Pennsylvania), Drew Weissman(California University of Pennsylvania), Mohamad‐Gabriel Alameh(Children's Hospital of Philadelphia), Xuexiang Han(Center for Excellence in Molecular Cell Science), Margaret M. Billingsley(Massachusetts Institute of Technology), C. Pritchett Frazee(University of Pennsylvania)
Cited by 121
Related Papers
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
|Immunity|2021|713
An ionizable lipid toolbox for RNA delivery
|Nature Communications|2021|581
Nanomaterial Delivery Systems for mRNA Vaccines
|Vaccines|2021|546